LipoSan Ultra™ Tests Well Against Placebo

LipoSan Ultra™ Tests Well Against Placebo

SCOTTSDALE, Ariz.--Vanson Inc.'s LipoSan Ultra™, the main ingredient in Baywood International's N-Cal™, may offer a statistically significant weight loss when compared to a placebo. In a double-blind, placebo-controlled study conducted by the Genesis Center for Integrative Medicine in Graham, Wash., 59 women were given 1.5 g twice a day of LipoSan Ultra™ or a placebo over an eight-week period, which included Thanksgiving and Christmas. Sixty-two percent of the LipoSan Ultra™ group lost weight, compared to 17 percent of the placebo group. The study did not call for a reduced-calorie diet or exercise program. Vanson expects this study to be published in a peer-reviewed journal later this year. For more information, visit www.bywd.com or visit Wilke Resources Inc. at Booth #1738-1740 at SupplySide East.